Michael Clark in Omaha, Nebraska

Home Nebraska Omaha

Michael Clark has Emergency Medicine as his primary medical specialty. Their primary office is: 7500 Mercy Rd in Omaha, Nebraska. There is an additional office location, for a total of two, for Michael Clark that can be viewed further down.

They're a part of the: Epn Of Nebraska Llc medical group which has around 21 members. You can call their office at 402-398-6060 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Texas Southwestern Medical School At Dallas and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael Clark Office Phone and Directions

Michael Clark
Epn Of Nebraska Llc
7500 Mercy Rd
Omaha, Nebraska 68124
402-398-6060

Patient Ratings
Please rate your experience with Michael Clark below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 402-398-6060

Enter a starting address:

Healthcare Info for Michael Clark

Medical School: University Of Texas Southwestern Medical School At Dallas
Graduation Year: 2018
The Primary Medical Specialty for Michael Clark is listed as: Emergency Medicine
Approximate Years of Experience: 6
PAC (PECOS ID)#: 5799032074
NPI #: 1730683921
NPI Created On: 03/21/2018
NPI Last Updated Listed as: 07/13/2021
Primary Taxonomy Code: 207P00000X
License Number:
S6596
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788624639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30